Jie Li
About Jie Li
Jie Li is a Senior Scientist known for conducting high-quality experiments to address delivery issues in gene therapy. He has a strong academic background and extensive research experience, having worked at various prestigious institutions including Mammoth Biosciences and the University of California, Berkeley.
Current Role at Mammoth Biosciences
Jie Li currently serves as a Senior Scientist at Mammoth Biosciences, a position held since 2022. In this role, Jie conducts high-quality, reproducible experiments aimed at addressing critical delivery issues in gene therapy. Jie previously worked at Mammoth Biosciences as a Scientist for a brief period from 2021 to 2022. The focus of Jie's work includes the development of innovative delivery vehicles for gene therapy, with an emphasis on proteins and RNAs.
Previous Experience in Research
Prior to joining Mammoth Biosciences, Jie Li accumulated extensive research experience. Jie worked at the University of California, Berkeley as a Postdoctoral Fellow since 2017. Before that, Jie was a Postdoctoral Fellow at City of Hope from 2016 to 2017. Jie also held roles as a Graduate Researcher and Postdoctoral Researcher at UCLA Chemical and Biomolecular Engineering from 2010 to 2016. Additionally, Jie was a Cooperative Researcher at KYTHERA Biopharmaceuticals from 2011 to 2013.
Educational Background
Jie Li has a solid educational foundation in chemical engineering and chemistry. Jie earned a Doctor of Philosophy (PhD) in Chemical Engineering from the University of California, Los Angeles, studying from 2010 to 2015. Prior to this, Jie completed a Bachelor of Engineering in Chemical Engineering at Tianjin University from 2006 to 2010. Jie also holds a Bachelor of Science in Chemistry from Nankai University, obtained during the same period.
Research Focus and Collaboration
Jie Li's research focuses on developing innovative delivery vehicles for gene therapy. This work involves addressing challenges related to the delivery of proteins and RNAs. Jie collaborates across various disciplines, including chemistry, medicine, and nanotechnology, to enhance the effectiveness of gene therapy solutions. This interdisciplinary approach is essential for tackling the complexities associated with gene delivery.